QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01X OTHER ANTINEOPLASTIC AGENTS
QL01XF Retinoids for cancer treatment
QL01XF01 tretinoin
QL01XF02 alitretinoin
QL01XF03 bexarotene
Last updated: 2022-12-22
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer